These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9915729)

  • 1. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails.
    Italian Study Group for the Di Bella Multitherapy Trials
    BMJ; 1999 Jan; 318(7178):224-8. PubMed ID: 9915729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas.
    Di Bella G; Colori B; Mascia F
    Neuro Endocrinol Lett; 2012; 33(8):773-81. PubMed ID: 23391973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unconventional Di Bella cancer treatment. A reflection on the Italian experience. The Italian Study Group for the Di Bella Multitherapy Trials.
    Traversa G; Maggini M; Menniti-Ippolito F; Bruzzi P; Chiarotti F; Greco D; Spila-Alegiani S; Raschetti R; Benagiano G
    Cancer; 1999 Nov; 86(10):1903-11. PubMed ID: 10570412
    [No Abstract]   [Full Text] [Related]  

  • 4. Results from a historical survey of the survival of cancer patients given Di Bella multitherapy.
    Buiatti E; Arniani S; Verdecchia A; Tomatis L
    Cancer; 1999 Nov; 86(10):2143-9. PubMed ID: 10570444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial.
    Todisco M; Casaccia P; Rossi N
    Cancer Biother Radiopharm; 2001 Apr; 16(2):171-7. PubMed ID: 11385964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.
    Di Bella G; Mascia F; Ricchi A; Colori B
    Neuro Endocrinol Lett; 2013; 34(7):660-8. PubMed ID: 24464005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of high-grade non-Hodgkin's lymphoma after autologous stem cell transplantation: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, melatonin, retinoids, and ACTH.
    Todisco M
    Am J Ther; 2006; 13(6):556-7. PubMed ID: 17122540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature.
    Di Bella G; Mascia F; Colori B
    Neuro Endocrinol Lett; 2013; 34(6):523-8. PubMed ID: 24378460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimentation with Di Bella polychemotherapy in Tuscany].
    Orlandini C; Amunni G; Conte PF; Francini G; Rossini GC; Vanni D;
    Epidemiol Prev; 2000; 24(5):209-12. PubMed ID: 11189475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade non-Hodgkin lymphoma at advanced stage: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, retinoids, and melatonin.
    Todisco M
    Am J Ther; 2007; 14(1):113-5. PubMed ID: 17303979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumor patients].
    Di Filippo F; Serraino D; Tirelli U
    Clin Ter; 1998; 149(4):261-5. PubMed ID: 9866886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments.
    Raschetti R; Greco D; Menniti-Ippolito F; Spila-Alegiani S; Benagiano G; Bruzzi P
    BMJ; 1999 Apr; 318(7190):1074. PubMed ID: 10336293
    [No Abstract]   [Full Text] [Related]  

  • 15. An unconventional cancer treatment lacking clinical efficacy remains available to Italian cancer patients.
    Merlo DF; Beccaro M; Costantini M;
    Tumori; 2008; 94(6):830-2. PubMed ID: 19267100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck.
    Di Bella G; Colori B
    Neuro Endocrinol Lett; 2012; 33(3):249-56. PubMed ID: 22635078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital fibrosarcoma in complete remission with Somatostatin, Bromocriptine, Retinoids, Vitamin D3, Vitamin E, Vitamin C, Melatonin, Calcium, Chondroitin sulfate associated with low doses of Cyclophosphamide in a 14-year Follow up.
    Di Bella G; Toscano R; Ricchi A; Colori B
    Neuro Endocrinol Lett; 2015; 36(8):725-33. PubMed ID: 26921571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.